[1]
Wigley JE. Eosinophilic Granuloma. ? Sarcoid of Boeck. Proceedings of the Royal Society of Medicine. 1945 Jan:38(3):125-6
[PubMed PMID: 19992999]
[2]
Oliveira CC, Ianhez PE, Marques SA, Marques ME. Granuloma faciale: clinical, morphological and immunohistochemical aspects in a series of 10 patients. Anais brasileiros de dermatologia. 2016 Nov-Dec:91(6):803-807. doi: 10.1590/abd1806-4841.20164628. Epub
[PubMed PMID: 28099604]
[3]
Ortonne N, Wechsler J, Bagot M, Grosshans E, Cribier B. Granuloma faciale: a clinicopathologic study of 66 patients. Journal of the American Academy of Dermatology. 2005 Dec:53(6):1002-9
[PubMed PMID: 16310061]
[4]
Deen J, Moloney TP, Muir J. Extrafacial Granuloma Faciale: A Case Report and Brief Review. Case reports in dermatology. 2017 May-Aug:9(2):79-85. doi: 10.1159/000477960. Epub 2017 Jul 13
[PubMed PMID: 28868005]
Level 3 (low-level) evidence
[5]
Lindhaus C, Elsner P. Granuloma Faciale Treatment: A Systematic Review. Acta dermato-venereologica. 2018 Jan 12:98(1):14-18. doi: 10.2340/00015555-2784. Epub
[PubMed PMID: 28880343]
Level 1 (high-level) evidence
[6]
Nigar E, Dhillon R, Carr E, Matin RN. Eosinophilic angiocentric fibrosis and extrafacial granuloma faciale. Histopathology. 2007 Nov:51(5):729-31
[PubMed PMID: 17927606]
[7]
Goldner R, Sina B. Granuloma faciale: the role of dapsone and prior irradiation on the cause of the disease. Cutis. 1984 May:33(5):478-9, 482
[PubMed PMID: 6478871]
[8]
Marcoval J, Moreno A, Peyr J. Granuloma faciale: a clinicopathological study of 11 cases. Journal of the American Academy of Dermatology. 2004 Aug:51(2):269-73
[PubMed PMID: 15280847]
Level 3 (low-level) evidence
[9]
Radin DA, Mehregan DR. Granuloma faciale: distribution of the lesions and review of the literature. Cutis. 2003 Sep:72(3):213-9; quiz 208
[PubMed PMID: 14533833]
[10]
Barnadas MA, Curell R, Alomar A. Direct immunofluorescence in granuloma faciale: a case report and review of literature. Journal of cutaneous pathology. 2006 Jul:33(7):508-11
[PubMed PMID: 16872475]
Level 3 (low-level) evidence
[11]
Lallas A, Sidiropoulos T, Lefaki I, Tzellos T, Sotiriou E, Apalla Z. Photoletter to the editor: Dermoscopy of granuloma faciale. Journal of dermatological case reports. 2012 Jun 30:6(2):59-60. doi: 10.3315/jdcr.2012.1101. Epub
[PubMed PMID: 22826723]
Level 3 (low-level) evidence
[12]
Ludwig E, Allam JP, Bieber T, Novak N. New treatment modalities for granuloma faciale. The British journal of dermatology. 2003 Sep:149(3):634-7
[PubMed PMID: 14511001]
[13]
Tomson N,Sterling JC,Salvary I, Granuloma faciale treated successfully with topical tacrolimus. Clinical and experimental dermatology. 2009 Apr;
[PubMed PMID: 19175788]
[14]
Frankel DH, Soltani K, Medenica MM, Rippon JW. Tinea of the face caused by Trichophyton rubrum with histologic changes of granuloma faciale. Journal of the American Academy of Dermatology. 1988 Feb:18(2 Pt 2):403-6
[PubMed PMID: 3343409]
[15]
Ziemer M, Koehler MJ, Weyers W. Erythema elevatum diutinum - a chronic leukocytoclastic vasculitis microscopically indistinguishable from granuloma faciale? Journal of cutaneous pathology. 2011 Nov:38(11):876-83. doi: 10.1111/j.1600-0560.2011.01760.x. Epub 2011 Aug 23
[PubMed PMID: 21883365]
[16]
Lima RS, Maquiné GÁ, Silva Junior RC, Schettini AP, Santos M. Granuloma faciale: a good therapeutic response with the use of topical tacrolimus. Anais brasileiros de dermatologia. 2015 Sep-Oct:90(5):735-7. doi: 10.1590/abd1806-4841.20153339. Epub
[PubMed PMID: 26560220]
[17]
Cecchi R, Pavesi M, Bartoli L, Brunetti L. Topical tacrolimus in the treatment of granuloma faciale. International journal of dermatology. 2010 Dec:49(12):1463-5. doi: 10.1111/j.1365-4632.2009.04317.x. Epub
[PubMed PMID: 21091691]
[18]
Pérez-Robayna N, Rodríguez-García C, González-Hernández S, Sánchez R, Guimerá F, Sáez M. Successful response to topical tacrolimus for a granuloma faciale in an elderly patient. Dermatology (Basel, Switzerland). 2009:219(4):359-60. doi: 10.1159/000243806. Epub 2009 Oct 1
[PubMed PMID: 19797891]
[19]
Mitchell D. Successful treatment of granuloma faciale with tacrolimus. Dermatology online journal. 2004 Oct 15:10(2):23
[PubMed PMID: 15530313]
[20]
Eetam I,Ertekin B,Unal I,Alper S, Granuloma faciale: Is it a new indication for pimecrolimus? A case report. The Journal of dermatological treatment. 2006;
[PubMed PMID: 16971320]
Level 3 (low-level) evidence
[21]
Marcoval J, Moreno A, Bordas X, Peyrí J. Granuloma faciale: treatment with topical tacrolimus. Journal of the American Academy of Dermatology. 2006 Nov:55(5 Suppl):S110-1
[PubMed PMID: 17052523]
[22]
Jedlicková H, Feit J, Semrádová V. Granuloma faciale successfully treated with topical tacrolimus: a case report. Acta dermatovenerologica Alpina, Pannonica, et Adriatica. 2008 Mar:17(1):34-6
[PubMed PMID: 18454269]
Level 3 (low-level) evidence
[23]
Patterson C, Coutts I. Granuloma faciale successfully treated with topical tacrolimus. The Australasian journal of dermatology. 2009 Aug:50(3):217-9. doi: 10.1111/j.1440-0960.2009.00543.x. Epub
[PubMed PMID: 19659988]
[24]
Dourmishev L, Ouzounova-Raykova V, Broshtilova V, Miteva L. Granuloma faciale effectively treated with topical pimecrolimus. Acta dermatovenerologica Croatica : ADC. 2014:22(4):305-7
[PubMed PMID: 25580794]
[25]
Dowlati B, Firooz A, Dowlati Y. Granuloma faciale: successful treatment of nine cases with a combination of cryotherapy and intralesional corticosteroid injection. International journal of dermatology. 1997 Jul:36(7):548-51
[PubMed PMID: 9268759]
Level 3 (low-level) evidence
[27]
Verma R, Das AL, Vaishampayan SS, Vaidya S. Keloidal granuloma faciale with extrafacial lesions. Indian journal of dermatology, venereology and leprology. 2005 Sep-Oct:71(5):345-7
[PubMed PMID: 16394461]
[28]
Mashood AA, Simeen-ber-Rahman. Granuloma faciale -- an unusual presentation. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. 2006 Apr:16(4):296-7
[PubMed PMID: 16624198]
[29]
De D, Kanwar AJ, Radotra BD, Gupta S. Extrafacial granuloma faciale: report of a case. Journal of the European Academy of Dermatology and Venereology : JEADV. 2007 Oct:21(9):1284-6
[PubMed PMID: 17894740]
Level 3 (low-level) evidence
[30]
Bakkour W, Madan V. Rhinophyma-like granuloma faciale successfully treated with carbon dioxide laser. The British journal of dermatology. 2014 Feb:170(2):474-5. doi: 10.1111/bjd.12649. Epub
[PubMed PMID: 24111815]
[31]
Babalola O, Zhang J, Kristjansson A, Whitaker-Worth D, McCusker M. Granuloma faciale treated with topical dapsone: a case report. Dermatology online journal. 2014 Aug 17:20(8):. pii: 13030/qt9q7520rx. Epub 2014 Aug 17
[PubMed PMID: 25148282]
Level 3 (low-level) evidence
[32]
Morgado-Carrasco D, Giavedoni P, Mascaró JM Jr, Iranzo P. Assessment of Treatment of Refractory Granuloma Faciale With Intralesional Rituximab. JAMA dermatology. 2018 Nov 1:154(11):1312-1315. doi: 10.1001/jamadermatol.2018.2681. Epub
[PubMed PMID: 30193300]
[33]
Holme SA, Laidler P, Holt PJ. Concurrent granuloma faciale and eosinophilic angiocentric fibrosis. The British journal of dermatology. 2005 Oct:153(4):851-3
[PubMed PMID: 16181479]
[34]
Gupta L, Naik H, Kumar NM, Kar HK. Granuloma faciale with extrafacial involvement and response to tacrolimus. Journal of cutaneous and aesthetic surgery. 2012 Apr:5(2):150-2. doi: 10.4103/0974-2077.99463. Epub
[PubMed PMID: 23060713]
[35]
Fumo G, Patta F, Milo C, Pilloni L, Atzori L. A nose for trouble. Diagnosis: Granuloma faciale. Indian journal of dermatology, venereology and leprology. 2015 Jan-Feb:81(1):93-4. doi: 10.4103/0378-6323.148604. Epub
[PubMed PMID: 25566920]
[36]
Zampeli E, Moutsopoulos HM. Dapsone: an old drug effective for subacute cutaneous lupus erythematosus. Rheumatology (Oxford, England). 2019 May 1:58(5):920-921. doi: 10.1093/rheumatology/key434. Epub
[PubMed PMID: 30615176]
[37]
Pfeiffer C, Wozel G. Dapsone and sulfones in dermatology: overview and update. Journal of the American Academy of Dermatology. 2003 Feb:48(2):308-9
[PubMed PMID: 12582416]
Level 3 (low-level) evidence
[38]
Yuan C, Bu W, Chen X, Gu H. A case of granuloma faciale successfully treated with oral prednisone, tranilast and thalidomide. Postepy dermatologii i alergologii. 2018 Feb:35(1):109-112. doi: 10.5114/ada.2018.73170. Epub 2018 Feb 20
[PubMed PMID: 29599681]
Level 3 (low-level) evidence
[39]
Sand FL, Thomsen SF. Off-label use of TNF-alpha inhibitors in a dermatological university department: retrospective evaluation of 118 patients. Dermatologic therapy. 2015 May-Jun:28(3):158-65. doi: 10.1111/dth.12222. Epub 2015 Mar 3
[PubMed PMID: 25731720]
Level 2 (mid-level) evidence
[40]
Wollina U, Karte K, Geyer A, Stuhlert A, Bocker T. Clofazimine in inflammatory facial dermatosis--granuloma faciale and lipogranulomatosis subcutanea (Rothmann-Makai). Acta dermato-venereologica. 1996 Jan:76(1):77-9
[PubMed PMID: 8721503]
[41]
Gómez-de la Fuente E, del Rio R, Rodriguez M, Guerra A, Rodriguez-Peralto JL, Iglesias L. Granuloma faciale mimicking rhinophyma: response to clofazimine. Acta dermato-venereologica. 2000 Mar-Apr:80(2):144
[PubMed PMID: 10877139]
[42]
Panagiotopoulos A, Anyfantakis V, Rallis E, Chasapi V, Stavropoulos P, Boubouka C, Katsambas A. Assessment of the efficacy of cryosurgery in the treatment of granuloma faciale. The British journal of dermatology. 2006 Feb:154(2):357-60
[PubMed PMID: 16433810]
[43]
Fikrle T, Pizinger K. Granuloma Faciale treated with 595-nm pulsed dye laser. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 2011 Jan:37(1):102-4. doi: 10.1111/j.1524-4725.2010.01823.x. Epub 2010 Nov 11
[PubMed PMID: 21070474]
[44]
Hruza GJ, Ammirati CT. Granuloma faciale treated with 595-nm pulsed dye laser. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 2011 Jul:37(7):1060-1. doi: 10.1111/j.1524-4725.2011.02035.x. Epub
[PubMed PMID: 21711410]
[45]
Cheung ST, Lanigan SW. Granuloma faciale treated with the pulsed-dye laser: a case series. Clinical and experimental dermatology. 2005 Jul:30(4):373-5
[PubMed PMID: 15953073]
Level 2 (mid-level) evidence
[46]
Erceg A, de Jong EM, van de Kerkhof PC, Seyger MM. The efficacy of pulsed dye laser treatment for inflammatory skin diseases: a systematic review. Journal of the American Academy of Dermatology. 2013 Oct:69(4):609-615.e8. doi: 10.1016/j.jaad.2013.03.029. Epub 2013 May 24
[PubMed PMID: 23711766]
Level 1 (high-level) evidence
[47]
Chung WK, Park GH, Kim CH, Chang SE, Lee MW, Choi JH, Moon KC, Koh JK. Keloidal granuloma faciale after CO2 laser treatment for melanocytic naevus. Journal of the European Academy of Dermatology and Venereology : JEADV. 2009 May:23(5):611-2
[PubMed PMID: 19415815]
[48]
Wheeland RG, Ashley JR, Smith DA, Ellis DL, Wheeland DN. Carbon dioxide laser treatment of granuloma faciale. The Journal of dermatologic surgery and oncology. 1984 Sep:10(9):730-3
[PubMed PMID: 6434613]
[49]
Apfelberg DB, Druker D, Maser MR, Lash H, Spence B Jr, Deneau D. Granuloma faciale. Treatment with the argon laser. Archives of dermatology. 1983 Jul:119(7):573-6
[PubMed PMID: 6859900]
[50]
Hudson LD. Granuloma faciale: treatment with topical psoralen and UVA. Journal of the American Academy of Dermatology. 1983 Apr:8(4):559
[PubMed PMID: 6853786]
[51]
Bergfeld WF, Scholes HT, Roenigk HH Jr. Granuloma faciale--treatment by dermabrasion. Report of a case. Cleveland Clinic quarterly. 1970 Oct:37(4):215-8
[PubMed PMID: 5520807]
Level 3 (low-level) evidence